Finance

Lists
603811:SHA
Zhejiang Cheng Yi Pharmaceutical Co Ltd
CNÂ¥6,76
-0,73%
(-0,050) 1D
15 Okt., 11:30:01 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 603811...
Open
CNÂ¥6,75
High
CNÂ¥6,83
Low
CNÂ¥6,70
Mkt. cap
3,14 mjd
Avg. vol.
4,48 m
Volume
2,02 m
Dividend
3,17%
Quarterly dividend
CNÂ¥0,05
Ex-dividend date
26 Jun. 2026
P/E ratio
17,14
52-wk high
CNÂ¥9,69
52-wk low
CNÂ¥6,61
EPS
CNÂ¥0,39
Shares outstanding
119,28 m
No. of employees
604
Open
CNÂ¥6,75
High
CNÂ¥6,83
Low
CNÂ¥6,70
Mkt. cap
3,14 mjd
Avg. vol.
4,48 m
Volume
2,02 m
Dividend
3,17%
Quarterly dividend
CNÂ¥0,05
Ex-dividend date
26 Jun. 2026
P/E ratio
17,14
52-wk high
CNÂ¥9,69
52-wk low
CNÂ¥6,61
EPS
CNÂ¥0,39
Shares outstanding
119,28 m
No. of employees
604
News stories
From web sources and news partners
About Zhejiang Cheng Yi Pharmaceutical Co Ltd
CEO-
Employees604
Founded1966
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
180,36 m
215,32 m
201,00 m
230,80 m
Cost of goods sold
39,95 m
80,88 m
60,39 m
70,74 m
Cost of revenue
39,95 m
80,88 m
60,39 m
70,74 m
Research and development expenses
12,28 m
12,53 m
12,82 m
10,41 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
92,78 m
88,61 m
78,44 m
93,07 m
Operating expense
104,85 m
107,45 m
96,13 m
106,54 m
Total operating expenses
144,80 m
188,32 m
156,51 m
177,27 m
Operating income
35,56 m
26,99 m
44,48 m
53,52 m
Other non operating income
-601,21 k
576,34 k
-31,10 k
17,04 k
EBT including unusual items
34,42 m
59,97 m
50,26 m
61,47 m
EBT excluding unusual items
42,48 m
31,93 m
48,05 m
60,68 m
Income tax expense
3,75 m
7,11 m
5,64 m
10,34 m
Effective tax rate
10,90%
11,86%
11,22%
16,83%
Other operating expenses
303,02 k
6,81 m
3,93 m
3,45 m
Net income
30,30 m
52,39 m
44,29 m
50,58 m
Net profit margin
16,80%
24,33%
22,04%
21,91%
Earnings per share
-
-
-
-
Interest and investment income
8,14 m
5,05 m
3,81 m
7,48 m
Interest expense
-865,53 k
-336,06 k
-212,33 k
-178,35 k
Net interest expenses
7,28 m
4,71 m
3,60 m
7,30 m
Depreciation and amortization charges
-
-
-
-
EBITDA
59,20 m
50,55 m
68,03 m
76,70 m
Gain or loss from assets sale
111,92 k
-21,06 m
-
-61,71 k
AI content may include mistakes. Learn more
Google-programme